Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2004-4-16
pubmed:abstractText
Toll-like receptors (TLRs) are a recently described family of immune receptors involved in the recognition of pathogen-associated molecular patterns (PAMPs). The central role of TLR-2 and TLR-4 in microbial responses suggests they may be implicated in the pathogenesis of human sepsis. We hypothesized that the incidence and outcome of sepsis would be influenced by the expression of TLR-2 and TLR-4 on monocytes. We have examined the expression of TLR-2 and TLR-4 mRNA and protein and their response to pro- and anti-inflammatory agents on monocytes from subjects in the intensive therapy unit (ITU) with and without Gram-negative, Gram-positive or polymicrobial sepsis. We compared these data to ITU and healthy control subjects. TLR-2 mRNA was significantly up-regulated on monocytes from subjects with both Gram-positive and Gram-negative sepsis. Similarly, we detected increased levels of TLR-2 protein on the surface of monocytes from sepsis subjects relative to ITU controls. TLR-4 mRNA was increased in Gram-positive subjects; however, there was no corresponding increase in TLR-4 protein. Although TLR-4 mRNA expression in healthy control monocytes could be modulated in vitro by culture with lipopolysaccharide or interleukin-10, this was not observed in monocytes obtained from sepsis and ITU control subjects, suggesting that septic and ITU control milieus may alter the immunoregulation of TLR-4 mRNA expression on monocytes. TLR-2 mRNA was not modulated in culture by any stimulus in any group. We suggest that expression and regulatory response of monocyte TLR-2, and to a lesser extent TLR-4 may be abnormal in human sepsis.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/15086396-10196138, http://linkedlifedata.com/resource/pubmed/commentcorrection/15086396-10225915, http://linkedlifedata.com/resource/pubmed/commentcorrection/15086396-10548109, http://linkedlifedata.com/resource/pubmed/commentcorrection/15086396-10559223, http://linkedlifedata.com/resource/pubmed/commentcorrection/15086396-10725699, http://linkedlifedata.com/resource/pubmed/commentcorrection/15086396-10786961, http://linkedlifedata.com/resource/pubmed/commentcorrection/15086396-10820283, http://linkedlifedata.com/resource/pubmed/commentcorrection/15086396-11044374, http://linkedlifedata.com/resource/pubmed/commentcorrection/15086396-11123299, http://linkedlifedata.com/resource/pubmed/commentcorrection/15086396-11160242, http://linkedlifedata.com/resource/pubmed/commentcorrection/15086396-11191641, http://linkedlifedata.com/resource/pubmed/commentcorrection/15086396-11261796, http://linkedlifedata.com/resource/pubmed/commentcorrection/15086396-11404392, http://linkedlifedata.com/resource/pubmed/commentcorrection/15086396-11672593, http://linkedlifedata.com/resource/pubmed/commentcorrection/15086396-11964313, http://linkedlifedata.com/resource/pubmed/commentcorrection/15086396-11971020, http://linkedlifedata.com/resource/pubmed/commentcorrection/15086396-12023360, http://linkedlifedata.com/resource/pubmed/commentcorrection/15086396-12133792, http://linkedlifedata.com/resource/pubmed/commentcorrection/15086396-12700374, http://linkedlifedata.com/resource/pubmed/commentcorrection/15086396-12752109, http://linkedlifedata.com/resource/pubmed/commentcorrection/15086396-12794424, http://linkedlifedata.com/resource/pubmed/commentcorrection/15086396-14568981, http://linkedlifedata.com/resource/pubmed/commentcorrection/15086396-7768603, http://linkedlifedata.com/resource/pubmed/commentcorrection/15086396-7907683, http://linkedlifedata.com/resource/pubmed/commentcorrection/15086396-8674326, http://linkedlifedata.com/resource/pubmed/commentcorrection/15086396-9176536, http://linkedlifedata.com/resource/pubmed/commentcorrection/15086396-9734942
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0009-9104
pubmed:author
pubmed:issnType
Print
pubmed:volume
136
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
312-9
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed-meshheading:15086396-Adult, pubmed-meshheading:15086396-Aged, pubmed-meshheading:15086396-Aged, 80 and over, pubmed-meshheading:15086396-Case-Control Studies, pubmed-meshheading:15086396-Female, pubmed-meshheading:15086396-Flow Cytometry, pubmed-meshheading:15086396-Humans, pubmed-meshheading:15086396-Male, pubmed-meshheading:15086396-Membrane Glycoproteins, pubmed-meshheading:15086396-Middle Aged, pubmed-meshheading:15086396-Monocytes, pubmed-meshheading:15086396-RNA, Messenger, pubmed-meshheading:15086396-Receptors, Cell Surface, pubmed-meshheading:15086396-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:15086396-Sepsis, pubmed-meshheading:15086396-Statistics, Nonparametric, pubmed-meshheading:15086396-Toll-Like Receptor 2, pubmed-meshheading:15086396-Toll-Like Receptor 4, pubmed-meshheading:15086396-Toll-Like Receptors
pubmed:year
2004
pubmed:articleTitle
Differential expression of Toll-like receptor (TLR)-2 and TLR-4 on monocytes in human sepsis.
pubmed:affiliation
Lung Research Group, University of Bristol Division of Medicine, Southmead Hospital, Bristol, UK. lynne.armstrong@bris.ac.uk
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't